Skip to main content
Log in

The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project

  • Published:
Quality of Life Research Aims and scope Submit manuscript

An Erratum to this article was published on 31 March 2012

Abstract

Purpose

Assessing the efficacy of treatment modalities for diabetic retinopathy (DR) from the patient’s perspective is restricted due to a lack of a comprehensive patient-reported outcome measure. We are developing a DR-specific quality of life (QoL) item bank, and we report here on the qualitative results from the first phase of this project.

Methods

Eight focus groups and 18 semi-structured interviews were conducted with 57 patients with DR. The sessions were transcribed verbatim and iteratively analysed using the constant comparative method and NVIVO software.

Results

Participants had a median age of 58 years (range 27–83 years). Twenty-seven (47%) participants had proliferative DR in the better eye, and 14 (25%) had clinically significant macular oedema. Nine QoL domains were identified, namely visual symptoms, ocular surface symptoms, vision-related activity limitation, mobility, emotional well-being, health concerns, convenience, social, and economic. Participants described many vision-related activity limitations, particularly under challenging lighting conditions; however, socioemotional issues were equally important. Participants felt frustrated due to their visual restrictions, concerned about further vision loss and had difficulty coping with this uncertainty. Restrictions on driving were pervasive, affecting transport, social life, relationships, responsibilities, work and independence.

Conclusions

Patients with DR experience many socioemotional issues in addition to vision-related activity limitations. Data from this study will be used to generate data for a DR-specific QoL item bank.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DME:

Diabetic macular oedema

DR:

Diabetic retinopathy

PRO:

Patient-reported outcome measure

QoL:

Quality of life

References

  1. Kocur, I., & Resnikoff, S. (2002). Visual impairment and blindness in Europe and their prevention. British Journal of Ophthalmology, 86(7), 716–722.

    Article  PubMed  CAS  Google Scholar 

  2. Cheung, N., & Wong, T. (2009). Diabetic retinopathy and systemic complications. In E. Duh (Ed.), Diabetic retinopathy (pp. 465–482). New Jersey: Humana Press.

    Google Scholar 

  3. Wong, T., & Klein, K. (2008). The epidemiology of eye diseases in diabetes. In J. Ekoé, et al. (Eds.), The epidemiology of diabetes mellitus (2nd ed., pp. 475–497). Oxford: Wiley.

    Chapter  Google Scholar 

  4. Frank, R. N. (2004). Diabetic retinopathy. New England Journal of Medicine, 350(1), 48–58.

    Article  PubMed  CAS  Google Scholar 

  5. Cheung, N., Mitchell, P., & Wong, T. (2010). Diabetic retinopathy. Lancet, 376(9735), 124–136.

    Article  PubMed  Google Scholar 

  6. Penn, J. S., et al. (2008). Vascular endothelial growth factor in eye disease. Progress in Retinal and Eye Research, 27(4), 331–371.

    Article  PubMed  CAS  Google Scholar 

  7. Nicholson, B. P., & Schachat, A. P. (2010). A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 248(7), 915–930.

    Article  PubMed  CAS  Google Scholar 

  8. Simo, R., & Hernandez, C. (2008). Intravitreous anti-VEGF for diabetic retinopathy: Hopes and fears for a new therapeutic strategy. Diabetologia, 51(9), 1574–1580.

    Article  PubMed  CAS  Google Scholar 

  9. Lamoureux, E. L., et al. (2010). Impact of diabetic retinopathy on vision-specific function. Ophthalmology, 117(4), 757–765.

    Article  PubMed  Google Scholar 

  10. Lamoureux, E. L., Hassell, J. B., & Keeffe, J. E. (2004). The impact of diabetic retinopathy on participation in daily living. Archives of Ophthalmology, 122(1), 84–88.

    Article  PubMed  Google Scholar 

  11. Cusick, M., et al. (2005). Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. American Journal of Ophthalmology, 139(6), 1042–1050.

    Article  PubMed  Google Scholar 

  12. Lloyd, A., et al. (2008). Health utility values associated with diabetic retinopathy. Diabetic Medicine, 25(5), 618–624.

    Article  PubMed  CAS  Google Scholar 

  13. Fenwick, E., et al. (2010). The impact of diabetic retinopathy: Understanding the patient’s perspective. British Journal of Ophthalmology, 95(6), 774–782.

    Article  PubMed  Google Scholar 

  14. Fenwick, E., et al. (2011). Social and emotional impact of diabetic retinopathy: A review. Clinical and Experimental Ophthalmology (Epub ahead of print).

  15. Devenney, R., O’Neil, S. (2010). The experience of diabetic retinopathy: A qualitative study. British Journal of Health Psychology (Epub ahead of print).

  16. Coyne, K. S., et al. (2004). The impact of diabetic retinopathy: Perspectives from patient focus groups. Family Practice, 21(4), 447–453.

    Article  PubMed  Google Scholar 

  17. Woodcock, A., et al. (2004). The influence of diabetic retinopathy on quality of life: Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Education and Counseling, 53(3), 365–383.

    Article  PubMed  Google Scholar 

  18. Oehlergiarratana, J., & Fitzgerald, R. G. (1980). Group-therapy with blind diabetics. Archives of General Psychiatry, 37(4), 463–467.

    Article  CAS  Google Scholar 

  19. Scanlon, P. H., et al. (2006). Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabetic Medicine, 23(1), 60–66.

    Article  PubMed  CAS  Google Scholar 

  20. Brose, L., & Bradley, C. (2009). Psychometric development of the individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL). Value Health, 14(6), 740–754.

    Google Scholar 

  21. Bradley, C., et al. (1999). The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Quality of Life Research, 8(1–2), 79–91.

    Article  PubMed  CAS  Google Scholar 

  22. Gothwal, V., et al. (2011). Multiplicative rating scales do not enable measurement of vision-related quality of life. Clinical and Experimental Ophthalmology, 94(1), 52–62.

    Google Scholar 

  23. Fung, C. H., & Hays, R. D. (2008). Prospects and challenges in using patient-reported outcomes in clinical practice. Quality of Life Research, 17(10), 1297–1302.

    Article  PubMed  Google Scholar 

  24. Lohr, K., & Zebrack, B. (2009). Using patient-reported outcomes in clinical practice: Challenges and opportunities. Quality of Life Research, 18(1), 99–107.

    Article  PubMed  Google Scholar 

  25. Lohr, K. N. (1992). Applications of health status assessment measures in clinical practice: Overview of the third conference on advances in health status assessment. Medical Care, 30(5), MS1–MS14.

    Google Scholar 

  26. Pesudovs, K., et al. (2007). The development, assessment, and selection of questionnaires. Optometry and Vision Science, 84(8), 663–674.

    Article  PubMed  Google Scholar 

  27. Pesudovs, K., Garamendi, E., & Elliott, D. B. (2006). The Contact Lens Impact on Quality of Life (CLIQ) Questionnaire: development and validation. Investigative Ophthalmology & Visual Science, 47(7), 2789–2796.

    Article  Google Scholar 

  28. Benarous, R., et al. (2011). Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. Investigative Ophthalmology & Visual Science (in press).

  29. Dirani, M., et al. (2011). Are obesity and anthropometry risk factors for diabetic retinopathy? The Diabetes Management Project (DMP). Investigative Ophthalmology & Visual Science (Epub ahead of print).

  30. Early Treatment Diabetic Retinopathy Study Research Group. (1991). Grading diabetic retinopathy from stereoscopic color fundus photographs- an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology, 98(5 suppl).

  31. International Clinical Classification of Diabetic Retinopathy Severity of Macular Oedema. (2002). American Academy of Ophthalmology.

  32. Marshall, M. (1996). Sampling for qualitative research. Family Practice, 13(6), 522–525.

    Article  PubMed  CAS  Google Scholar 

  33. Maykut, P., & Morehouse, R. (1994). Beginning qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks, CA: Sage.

    Google Scholar 

  34. Rice, P., & Ezzy, D. (1999). Qualitative research methods: A health focus. Oxford: Oxford University Press.

    Google Scholar 

  35. Vaughn, S., Schumm, J., & Sinagub, J. (1996). Focus group interviews in education and psychology. California: Sage.

    Google Scholar 

  36. Wilkinson, S. (2004). Focus group research. In D. Silverman (Ed.), Qualitative research: Theory, method, practice (pp. 177–199). London: Sage.

    Google Scholar 

  37. Parrot, W. (2001). Emotions in social psychology. Philadelphia: Psychology Press.

    Google Scholar 

  38. Thoits, P. A. (1986). Social support and coping assistance. Journal of Consulting and Clinical Psychology, 54(4), 416–423.

    Article  PubMed  CAS  Google Scholar 

  39. Kessler, R. C., Price, R. H., & Wortman, C. B. (1985). Social-factors in psychopathology—Stress, social support, and coping processes. Annual Review of Psychology, 36, 531–572.

    Article  PubMed  CAS  Google Scholar 

  40. Holahan, C. J., et al. (1995). Social support, coping, and depressive symptoms in a late-middle-aged sample of patients reporting cardiac illness. Health Psychology, 14(2), 152–163.

    Article  PubMed  CAS  Google Scholar 

  41. Broman, A. T., et al. (2002). The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Investigative Ophthalmology & Visual Science, 43(11), 3393–3398.

    Google Scholar 

  42. Gabrielian, A., et al. (2010). The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye, 24(1), 29–35.

    Article  PubMed  CAS  Google Scholar 

  43. Owsley, C., et al. (2007). Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology, 114(9), 1728–1735.

    Article  PubMed  Google Scholar 

  44. Owsley, C., et al. (2006). Development of a questionnaire to assess vision problems under low luminance in agerelated maculopathy. Investigative Ophthalmology & Visual Science, 47(2), 528–535.

    Google Scholar 

  45. Owsley, C., et al. (2006). Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Investigative Ophthalmology & Visual Science, 47(4), 1310–1318.

    Article  Google Scholar 

  46. Lamoureux, E. L., et al. (2007). Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? Optometry and Vision Science, 84(8), 789–796.

    Article  PubMed  Google Scholar 

  47. Mangione, C. M., et al. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.

    PubMed  CAS  Google Scholar 

  48. Lamoureux, E. L., et al. (2007). The Impact of Vision Impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and Rasch analysis. Investigative Ophthalmology & Visual Science, 48(3), 1001–1006.

    Article  Google Scholar 

  49. Ware, J. E., Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.

    Article  PubMed  Google Scholar 

  50. Pesudovs, K. (2010). Item banking: A generational change in patient-reported outcome measurement. Optometry and Vision Science, 87(4), 1–9.

    Article  Google Scholar 

  51. Revicki, D. A., & Cella, D. F. (1997). Health status assessment for the twenty-first century: Item response theory, item banking and computer adaptive testing. Quality of Life Research, 6(6), 595–600.

    Article  PubMed  CAS  Google Scholar 

  52. Forkmann, T., et al. (2009). Development of an item bank for the assessment of depression in persons with mental illnesses and physical diseases using Rasch analysis. Rehabilitation Psychology, 54(2), 186–197.

    Article  PubMed  Google Scholar 

  53. Gershon, R. C. (2005). Computer adaptive testing. Journal of Applied Measurement, 6(1), 109–127.

    PubMed  Google Scholar 

Download references

Acknowledgments

CERA receives Operational Infrastructure Support from the Victorian Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ecosse L. Lamoureux.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 43 kb)

Appendix: moderator’s guide for the focus group and interview discussions

Appendix: moderator’s guide for the focus group and interview discussions

Warm up questions

Let’s start by getting to know each other. Let’s go around the group. Briefly, please let us know your name and how long you have had diabetes.

Questions and prompts

We are interested today in your diabetic eye problems and how they impact on your life.

Symptoms

First, what are some of the symptoms you experience as a result of your diabetic eye problems?

Can you describe your eyesight/vision?

How well can you see?

What factors influence your vision?

Impact on QoL

How do your eye problems impact on your QoL?

What areas of your life are affected by your diabetic eye problems?

How much would you say your diabetic eye problems impact on your QoL?

What things are harder to do because of vision loss from your diabetic eye problems?

Can you think of specific examples where your diabetic eye problem has caused you or someone else difficulty?

Do you need help from others for some things because of your eye problems?

Depending on responses so far

In other groups I have talked to many people about how their diabetic eye problems affect them emotionally. I’m interested in your experience of this.

Can you describe how your diabetic eye problems make you feel emotionally?

How do you feel about your eye problems?

Can you describe some of your emotional reactions to vision loss?

In what ways do your diabetic eye problems affect your social or family life?

What things are you missing out on because of your vision?

What social occasions or leisure activities are affected by your vision loss?

How has your eye problem affected your family and personal relationships?

Thinking about travelling and getting out and about, can you describe how your diabetes eye problems have affected this?

What things are most difficult when travelling outside or in crowded places?

What do you find difficult when moving about in your own home?

In what ways have your diabetic eye problems impacted on your work life?

What aspects of your work are harder to do?

How have your diabetic eye problems impacted on you financially?

What things have cost you money because of your diabetic eye problems?

How about managing your diabetes? In what ways do your diabetic eye problems affect this?

What things [e.g. insulin shots, glucose monitoring, exercise] are hard to do because of your vision loss?

Finally, what is the worst thing about having diabetic eye disease?

What do you find the most annoying about your vision loss from diabetes?

Thank you all very much for sharing your experiences. I know this can be a difficult area to discuss but your input has been really valuable. Before we move on, I will briefly summarise what we have discussed so far….

Is there anything else you’d like to add to this before we move on?

Treatment and impact

I’d now like to move on to talk about eye treatments.

Has anyone had any treatment for their diabetic eye problems? What was it?

What were your experiences with this treatment?

What side effects, if any, have you experienced?

In what ways has your treatment experience affected your QoL?

Useful prompts to use throughout the focus group:

Are there any other views on this?

Is there anything else?

Would you explain further?

Can you give me an example of what you mean?

Summary

We are reaching the end of our time now. I would like to summarise the key ideas that I have heard….

Is there anything I have missed or that you would like to add to my summary?

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fenwick, E.K., Pesudovs, K., Khadka, J. et al. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res 21, 1771–1782 (2012). https://doi.org/10.1007/s11136-012-0110-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-012-0110-1

Keywords

Navigation